For those following the NAM discussions in the US and EU, the EU has just advanced its position and plan in this Roadmap.
The Objectives of the Roadmap section starts with a very clear set of statements on its intent:
"This roadmap sets out the clear objective and concrete steps needed to transition from traditional animal testing methods to innovative non-animal approaches. At the same time, it maintains an unyielding commitment to preserve the integrity of safety evaluations, which ensure a high level of protection for human and animal health and the environment. Non-animal approaches must deliver a level of protection equivalent to that of currently established methods.
The roadmap is accompanied by a Staff Working Document (SWD(2026) 144) that lays out in detail the evidence base supporting the proposed actions."
The remainder of the 26-page Communication goes into details on the approaches to be used, including working with organizations outside the EU.
Links to both documents are below.
Here's a link to the report:
https://single-market-economy.ec.europa.eu/document/download/dff698bf-4852-4898-9f0d-7878382fbff6_en?filename=C_2026_3497_F1_COMMUNICATION_FROM_COMMISSION_EN_V4_P1_4771149.PDF
There is a Staff support document:https://single-market-economy.ec.europa.eu/document/download/4afe05f9-35ec-46b7-83bd-a9ae95111916_en?filename=SWD_2026_144_F1_OTHER_STAFF_WORKING_PAPER_EN_V3_P1_4772629.PDF
What led me to this Roadmap was a Commentary "Europe's Roadmap Finally Arrives: Long on Rigor, Short on a Clock" on the Roadmap by Thomas Hartung ( https://altex.org/index.php/altex/article/view/3213/3003 ) - a worthwhile read and perspective.
------------------------------
Mark Arnold Ph.D., FAAPS
Westampton, NJ
[email protected]Bioanalytical Solution Integration
LinkedIn:
https://www.linkedin.com/in/markearnoldphd/Website & Blog: Bioanalysis & Biomarkers <bioanalysisandbiomarkers.blogspot.com>
------------------------------
</bioanalysisandbiomarkers.blogspot.com>